查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
分子診斷的全球市場(2022年)
市場調查報告書
商品編碼
1127677

分子診斷的全球市場(2022年)

Molecular Diagnostics Global Market Report 2022
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

全球分子診斷的市場規模預測將從2021年的494億9,000萬美元，在2022年達到496億4,000萬美元，以年複合成長率0.3％成長。此外到2026年前將減少到477億8,000萬美元，以年複合成長率-1.0％成長。感染疾病和各種形態的癌症流行，推動了該市場的成長。

本報告提供全球分子診斷市場相關調查分析，提供市場特徵，市場區隔分析，地區分析，競爭情形等資訊。

目錄

第1章 摘要整理

第2章 分子診斷市場特徵

第3章 分子診斷的市場規模與成長

  • 全球分子診斷市場實際成果(2016年～2021年)
    • 推動市場要素
    • 阻礙市場要素
  • 全球分子診斷市場預測(2021年～2026年)(2031年)
    • 推動市場要素
    • 阻礙市場要素

第4章 分子診斷市場區隔

  • 全球分子診斷市場:各技術，實際成果與預測
  • 聚合酵素鏈鎖反應(PCR)
  • DNA定序
  • 次世代定序
  • 全球分子診斷市場:各產品，實際成果與預測
  • 器具
  • 試劑·消耗品
  • 軟體·服務
  • 全球分子診斷市場:各用途，實際成果與預測
  • 腫瘤學
  • 藥物基因體學
  • 感染疾病
  • 遺傳基因檢驗
  • 神經疾病
  • 循環系統疾病
  • 微生物學
  • 其他
  • 全球分子診斷市場:各終端用戶，實際成果與預測
  • 醫院
  • 研究所
  • 其他(血液銀行，居家醫療機關，看護設施)

第5章 分子診斷市場各地區·各國分析

  • 全球分子診斷市場:各地區，實際成果與預測
  • 全球分子診斷市場:各國，實際成果與預測

第6章 亞太地區的分子診斷市場

  • 亞太地區的分子診斷市場概要
  • 亞太地區的分子診斷市場:各技術，實際成果與預測

第7章 中國的分子診斷市場

  • 中國的分子診斷市場概要
  • 中國的分子診斷市場:各技術，實際成果與預測

第8章 印度的分子診斷市場

  • 印度的分子診斷市場概要
  • 印度的分子診斷市場:各技術，實際成果與預測

第9章 日本的分子診斷市場

  • 日本的分子診斷市場概要
  • 日本的分子診斷市場:各技術，實際成果與預測

第10章 澳洲的分子診斷市場

  • 澳洲的分子診斷市場:各技術，實際成果與預測

第11章 印尼的分子診斷市場

  • 印尼的分子診斷市場:各技術，實際成果與預測

第12章 韓國的分子診斷市場

  • 韓國的分子診斷市場:各技術，實際成果與預測

第13章 西歐的分子診斷市場

  • 西歐的分子診斷市場概要
  • 西歐的分子診斷市場:各技術，實際成果與預測

第14章 英國的分子診斷市場

  • 英國的分子診斷市場概要
  • 英國的分子診斷市場:各技術，實際成果與預測

第15章 德國的分子診斷市場

  • 德國的分子診斷市場:各技術，實際成果與預測

第16章 法國的分子診斷市場

  • 法國的分子診斷市場:各技術，實際成果與預測

第17章 東歐的分子診斷市場

  • 東歐的分子診斷市場概要
  • 東歐的分子診斷市場:各技術，實際成果與預測

第18章 俄羅斯的分子診斷市場

  • 俄羅斯的分子診斷市場:各技術，實際成果與預測

第19章 北美的分子診斷市場

  • 北美的分子診斷市場概要
  • 北美的分子診斷市場:各技術，實際成果與預測

第20章 美國的分子診斷市場

  • 美國的分子診斷市場概要
  • 美國的分子診斷市場:各技術，實際成果與預測

第21章 南美的分子診斷市場

  • 南美的分子診斷市場概要
  • 南美的分子診斷市場:各技術，實際成果與預測

第22章 巴西的分子診斷市場

  • 巴西的分子診斷市場:各技術，實際成果與預測

第23章 中東的分子診斷市場

  • 中東的分子診斷市場概要
  • 中東的分子診斷市場:各技術，實際成果與預測

第24章 非洲的分子診斷市場

  • 非洲的分子診斷市場概要
  • 非洲的分子診斷市場:各技術，實際成果與預測

第25章 分子診斷市場競爭情形和企業簡介

  • 分子診斷市場競爭情形
  • 分子診斷市場企業簡介
    • Becton
    • BioMerieux SA.
    • Danaher Corporation
    • Grifols
    • Hologic Inc.

第26章 分子診斷市場上主要合併和收購

第27章 分子診斷市場趨勢與策略

第28章 分子診斷市場未來預測潛在的分析

第29章 附錄

簡介目錄
Product Code: h2524

“Molecular Diagnostics Global Market Report 2022 ” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global Molecular Diagnostics market.

This report focuses on Molecular Diagnostics market which is experiencing strong growth. The report gives a guide to the Molecular Diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the Molecular Diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Molecular Diagnostics global market report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Molecular Diagnostics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The Molecular Diagnostics market section of the report gives context. It compares the Molecular Diagnostics market with other segments of the Molecular Diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, Molecular Diagnostics indicators comparison.

Scope

Markets Covered:

1) By Technology: Polymerase Chain Reaction (PCR), DNA Sequencing, Next-Generation Sequencing

2) By Product: Instruments, Reagents and Consumables, Software & Services

3) By Application: Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, Others

4) By End-User: Hospitals, Laboratories, Others (Blood Banks, Home Health Agencies, and Nursing Homes)

Companies Mentioned: Becton, BioMerieux SA., Danaher Corporation, Grifols, Hologic Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary

The major players in the molecular diagnostics market are: Becton, BioMerieux SA., Danaher Corporation, Grifols, Hologic Inc., Novartis AG, QIAGEN, Siemens Healthcare GmbH, Abbott, and Dickinson and Company.

The global molecular diagnostics market is expected to grow from $49.49 billion in 2021 to $49.64 billion in 2022 at a compound annual growth rate (CAGR) of 0.3%. The molecular diagnostics market is expected to decline to $47.78 billion in 2026 at a compound annual growth rate (CAGR) of -1.0%.

The molecular diagnostics market consists of sales of molecular diagnostics services and related products by entities (organizations, sole traders, partnership) that are utilised to direct patient management, from diagnosis to treatment, especially in the treatment of congenital anomalies, infectious diseases, and cancer. Molecular diagnostic is a term used to describe a class of techniques that are used to examine biological markers in the genetic code (genome) of an organism and to determine how their cells express their genes as proteins.

The main types of products of molecular diagnostics are instruments, reagents, consumables, software, and services. Instruments refer to a measuring device for determining the present value of a quantity under observation. The technologies include polymerase chain reaction (PCR), DNA sequencing, and next-generation sequencing and these are used in oncology, pharmacogenomics, infectious diseases, genetic testing, neurological disease, cardiovascular disease, microbiology, and other applications. The various end-users are hospitals, laboratories, and other end-users (blood banks, home health agencies, and nursing homes).

North America was the largest region in the molecular diagnostics market in 2021. The regions covered in molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The rising prevalence of infectious diseases and cancers of different forms drives the molecular diagnostics market. To determine whether mutations to a gene or chromosome may raise a person's chance of acquiring cancer or other disorders, molecular testing is employed. The increasing prevalence of infectious diseases and various types of cancer creates a demand for new diagnostic procedures including fast and specific molecular diagnostic tests. For instance, in 2020, according to National Cancer Institute, a US-based government agency, an estimated 1,806,590 new cases of cancer would be diagnosed in the United States and 606,520 people would die from the disease. Therefore, the increasing prevalence of cancer is driving the growth of the molecular diagnostic market.

The advances in genomics and proteomics are a key trend gaining popularity in the molecular diagnostics market. Polymerase chain reaction (PCR) is a recent development in genomics and helps in discovering new approaches to molecular diagnosis for disease diagnosis and pathogenesis of diseases. This enables better monitoring and a fast diagnosis and major organizations are investing to have a competitive edge. Following the trend, $600 million to support COVID-19 vaccine and therapy clinical trials led by the private sector, and for Canadian bio-manufacturing opportunities. This announcement was part of the $1 billion Plan to Mobilize Science. The growing research in proteomics and genomics will help develop more advanced molecular diagnostic techniques in the forecast period.

In April 2021, Hologic, a US-based women's health technology company, acquired Mobidiag Oy for an undisclosed amount. The acquisition would accelerate the global growth of Mobidiag's molecular diagnostic test platforms, which offer ease of use, multiplex capability, and rapid turnaround time. Mobidiag Oy is a Finland-based company that develops and provides molecular diagnostics for infectious diseases and antibiotic resistance.

The countries covered in the molecular diagnostics market are: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia."

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Market Characteristics

3. Molecular Diagnostics Market Size And Growth

  • 3.1. Global Molecular Diagnostics Historic Market, 2016-2021, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Molecular Diagnostics Forecast Market, 2021-2026F, 2031F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Molecular Diagnostics Market Segmentation

  • 4.1. Global Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Polymerase Chain Rreaction (PCR)
  • DNA Sequencing
  • Next-Generation Sequencing
  • 4.2. Global Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Instruments
  • Reagents and Consumables
  • Software & Services
  • 4.3. Global Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oncology
  • Pharmacogenomics
  • Infectious Diseases
  • Genetic Testing
  • Neurological Disease
  • Cardiovascular Disease
  • Microbiology
  • Others
  • 4.4. Global Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals
  • Laboratories
  • Others (Blood Banks, Home Health Agencies, and Nursing Homes)

5. Molecular Diagnostics Market Regional And Country Analysis

  • 5.1. Global Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 5.2. Global Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

6. Asia-Pacific Molecular Diagnostics Market

  • 6.1. Asia-Pacific Molecular Diagnostics Market Overview
  • 6.2. Asia-Pacific Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7. China Molecular Diagnostics Market

  • 7.1. China Molecular Diagnostics Market Overview
  • 7.2. China Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

8. India Molecular Diagnostics Market

  • 8.1. India Molecular Diagnostics Market Overview
  • 8.2. India Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. Japan Molecular Diagnostics Market

  • 9.1. Japan Molecular Diagnostics Market Overview
  • 9.2. Japan Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

10. Australia Molecular Diagnostics Market

  • 10.1. Australia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Indonesia Molecular Diagnostics Market

  • 11.1. Indonesia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. South Korea Molecular Diagnostics Market

  • 12.1. South Korea Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Western Europe Molecular Diagnostics Market

  • 13.1. Western Europe Molecular Diagnostics Market Overview
  • 13.2. Western Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. UK Molecular Diagnostics Market

  • 14.1. UK Molecular Diagnostics Market Overview
  • 14.2. UK Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Germany Molecular Diagnostics Market

  • 15.1. Germany Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. France Molecular Diagnostics Market

  • 16.3. France Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Eastern Europe Molecular Diagnostics Market

  • 17.1. Eastern Europe Molecular Diagnostics Market Overview
  • 17.2. Eastern Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. Russia Molecular Diagnostics Market

  • 18.1. Russia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. North America Molecular Diagnostics Market

  • 19.1. North America Molecular Diagnostics Market Overview
  • 19.2. North America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. USA Molecular Diagnostics Market

  • 20.1. USA Molecular Diagnostics Market Overview
  • 20.2. USA Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. South America Molecular Diagnostics Market

  • 21.1. South America Molecular Diagnostics Market Overview
  • 21.2. South America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. Brazil Molecular Diagnostics Market

  • 22.1. Brazil Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. Middle East Molecular Diagnostics Market

  • 23.1. Middle East Molecular Diagnostics Market Overview
  • 23.2. Middle East Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Africa Molecular Diagnostics Market

  • 24.1. Africa Molecular Diagnostics Market Overview
  • 24.2. Africa Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 25.1. Molecular Diagnostics Market Competitive Landscape
  • 25.2. Molecular Diagnostics Market Company Profiles
    • 25.2.1. Becton
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. BioMerieux SA.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Danaher Corporation
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Grifols
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Hologic Inc.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Molecular Diagnostics Market

27. Molecular Diagnostics Market Trends And Strategies

28. Molecular Diagnostics Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer